Skip to main content

Table 2 Comparison of treatments and prognoses

From: Anaemia is an essential complication of ANCA-associated renal vasculitis: a single center cohort study

  All patients Min Hb <7.5 Min Hb ≥7.5 P Value
Treatment
 Blood transfusion of RBC, n (%) 13 (29) 12 (50) 1 (5) 0.001
 Use of ESAs, n (%) 20 (44) 16 (67) 4 (19) 0.001
 Plasma exchange therapy, n (%) 6 (13) 6 (25) 0 (0) 0.01
 Steroid pulse therapy, n (%) 20 (44) 13 (54) 7 (33) 0.16
 Use of CY within 4 weeks after treatment initiation, n (%) 1 (2) 1 (4) 0 (0) 0.33
 Use of CY within 12 weeks after treatment initiation, n (%) 14 (35) 9 (47) 5 (24) 0.12
Prognosis
 Duration of hospitalization (days) 70 ± 26 75 ± 28 65 ± 23 0.23
 Number of deaths during the first hospitalization, n (%) 4 (9) 4 (17) 0 (0) 0.05
 Number of deaths at last follow-up, n (%) 11 (24) 8 (33) 3(14) 0.14
 Number of patients with end-stage kidney disease at last follow-up, n (%) 2 (4) 2 (8) 0 (0) 0.18
  1. Values are shown as the numbers of patients or the mean ± SD. Abbreviations: Min Hb Minimum haemoglobin, RBC Red blood cell, ESAs Erythropoiesis-stimulating agents, CY Cyclophosphamide